These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24429187)

  • 1. Anti-acid treatment for idiopathic pulmonary fibrosis.
    Tzouvelekis A; Bouros D
    Lancet Respir Med; 2013 Jul; 1(5):348-9. PubMed ID: 24429187
    [No Abstract]   [Full Text] [Related]  

  • 2. Idiopathic pulmonary fibrosis: increased survival with "gastroesophageal reflux therapy": fact or fallacy?
    Raghu G
    Am J Respir Crit Care Med; 2011 Dec; 184(12):1330-2. PubMed ID: 22174112
    [No Abstract]   [Full Text] [Related]  

  • 3. Antacid therapy in idiopathic pulmonary fibrosis: more questions than answers?
    Johannson KA; Strâmbu I; Ravaglia C; Grutters JC; Valenzuela C; Mogulkoc N; Luppi F; Richeldi L; Wells AU; Vancheri C; Kreuter M;
    Lancet Respir Med; 2017 Jul; 5(7):591-598. PubMed ID: 28664861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials.
    Lee JS; Collard HR; Anstrom KJ; Martinez FJ; Noth I; Roberts RS; Yow E; Raghu G;
    Lancet Respir Med; 2013 Jul; 1(5):369-76. PubMed ID: 24429201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antacid Therapy and Disease Progression in Patients with Idiopathic Pulmonary Fibrosis Who Received Pirfenidone.
    Kreuter M; Spagnolo P; Wuyts W; Renzoni E; Koschel D; Bonella F; Maher TM; Kolb M; Weycker D; Kirchgässler KU; Costabel U
    Respiration; 2017; 93(6):415-423. PubMed ID: 28399537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ANTISECRETORY TREATMENT FOR PEDIATRIC GASTROESOPHAGEAL REFLUX DISEASE - A SYSTEMATIC REVIEW.
    Mattos ÂZ; Marchese GM; Fonseca BB; Kupski C; Machado MB
    Arq Gastroenterol; 2017 Dec; 54(4):271-280. PubMed ID: 28954042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reflux in idiopathic pulmonary fibrosis.
    Minnis P; Henry K; Keane MP
    QJM; 2016 Jan; 109(1):7-10. PubMed ID: 26319930
    [No Abstract]   [Full Text] [Related]  

  • 8. PHARMACOLOGICAL TREATMENT OF CHILDREN WITH GASTRO-ESOPHAGEAL REFLUX: A SUMMARY.
    Gaines C
    Gastroenterol Nurs; 2016; 39(1):68-70. PubMed ID: 26825568
    [No Abstract]   [Full Text] [Related]  

  • 9. Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis.
    Lee JS; Ryu JH; Elicker BM; Lydell CP; Jones KD; Wolters PJ; King TE; Collard HR
    Am J Respir Crit Care Med; 2011 Dec; 184(12):1390-4. PubMed ID: 21700909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited efficacy of antigastroesophageal reflux medications in children.
    Berman J
    J Pediatr; 2015 May; 166(5):1321-2. PubMed ID: 25919740
    [No Abstract]   [Full Text] [Related]  

  • 11. Valuable heartburn data that may be difficult to swallow.
    Alverdy JC
    Surg Obes Relat Dis; 2015; 11(1):229. PubMed ID: 25264324
    [No Abstract]   [Full Text] [Related]  

  • 12. [Night acid "bursting": treatment of patients with gastroesophageal reflux disease].
    Vasil'ev IuV; Beliaeva VS
    Eksp Klin Gastroenterol; 2007; (3):83-91. PubMed ID: 17937011
    [No Abstract]   [Full Text] [Related]  

  • 13. Uses and abuses of acid-suppression therapy in children.
    Hassall E
    J Pediatr Gastroenterol Nutr; 2011 Dec; 53 Suppl 2():S8-9. PubMed ID: 22235449
    [No Abstract]   [Full Text] [Related]  

  • 14. Combination therapy.
    Katz P
    Postgrad Med; 2000 May; 107(5 Suppl):31-3; discussion 33-4. PubMed ID: 19667512
    [No Abstract]   [Full Text] [Related]  

  • 15. Medical management vs. surgery for gastroesophageal reflux disease.
    Kripke C
    Am Fam Physician; 2010 Aug; 82(3):244. PubMed ID: 20672787
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial: anti-secretory therapy prior to anti-reflux surgery. Does dose matter?
    Schnoll-Sussman F; Katz PO
    Aliment Pharmacol Ther; 2015 Sep; 42(5):626. PubMed ID: 26238577
    [No Abstract]   [Full Text] [Related]  

  • 17. On-demand requirements of patients with endoscopy-negative gastro-oesophageal reflux disease: H2-blocker vs. proton pump inhibitor.
    Juul-Hansen P; Rydning A
    Aliment Pharmacol Ther; 2009 Jan; 29(2):207-12. PubMed ID: 19006541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical therapy for gastroesophageal reflux disease in 2007.
    Katz PO
    Rev Gastroenterol Disord; 2007; 7(4):193-203. PubMed ID: 18192955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of H2-receptor antagonist and proton pomp inhibitor on the treatment of acid-related disease].
    Kawai T; Yagi K; Moriyasu F
    Nihon Rinsho; 2015 Jul; 73(7):1159-62. PubMed ID: 26165073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metoclopramide, H2 blockers, and proton pump inhibitors: pharmacotherapy for gastroesophageal reflux in neonates.
    Malcolm WF; Cotten CM
    Clin Perinatol; 2012 Mar; 39(1):99-109. PubMed ID: 22341540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.